|
ATPBD4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.562400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.584200E-01 |
| Normal-vs-Stage2 |
7.960400E-01 |
| Normal-vs-Stage3 |
2.465600E-01 |
| Normal-vs-Stage4 |
2.335800E-01 |
| Stage1-vs-Stage2 |
8.167800E-01 |
| Stage1-vs-Stage3 |
2.641000E-01 |
| Stage1-vs-Stage4 |
4.367400E-01 |
| Stage2-vs-Stage3 |
2.640000E-01 |
| Stage2-vs-Stage4 |
2.919800E-01 |
| Stage3-vs-Stage4 |
9.647600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.327200E-01 |
| Normal-vs-AfricanAmerican |
2.150400E-01 |
| Normal-vs-Asian |
8.148800E-01 |
| Caucasian-vs-AfricanAmerican |
1.406970E-01 |
| Caucasian-vs-Asian |
8.383400E-01 |
| AfricanAmerican-vs-Asian |
4.379400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.251200E-01 |
| Normal-vs-Female |
8.650800E-01 |
| Male-vs-Female |
5.238400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.997000E-01 |
| Normal-vs-Extreme_Weight |
5.412000E-01 |
| Normal-vs-Obese |
2.443800E-01 |
| Normal-vs-Extreme_Obese |
7.474400E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.715000E-01 |
| Normal_Weight-vs-Obese |
5.047600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.715400E-01 |
| Extreme_Weight-vs-Obese |
1.104990E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.458200E-01 |
| Obese-vs-Extreme_Obese |
7.245800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.283200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.619200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.800400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.942800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.415600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.538400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.113400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.705810E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.490000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.469200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.406000E-01 |
| Normal-VS-Type2 PRCC |
8.961900E-02 |
| Normal-VS-KIRP CIMP |
1.779670E-03 |
| Normal-VS-Unclassified PRCC |
7.684400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.074300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.574310E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.895800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.706960E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.132810E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.382100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.432600E-01 |
| Normal-vs-N1 |
1.677680E-02 |
| Normal-vs-N2 |
2.916000E-01 |
| N0-vs-N1 |
1.718960E-01 |
| N0-vs-N2 |
7.297400E-01 |
| N1-vs-N2 |
7.629400E-01 |
|
|
